February 26, 2020 / 10:47 PM / a month ago

BRIEF-Cyclacel Pharmaceuticals Reports Fourth-Quarter Results

Feb 26 (Reuters) - Cyclacel Pharmaceuticals Inc:

* CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* QTRLY NET LOSS PER SHARE – BASIC AND DILUTED $0.17

* CYCLACEL PHARMACEUTICALS- AS OF DEC 31, 2019, CASH AND CASH EQUIVALENTS TOTALED $11.9 MILLION, COMPARED TO $17.5 MILLION AS OF DECEMBER 31, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below